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Editorial
Preventing Occupational Cancer
by Richard R. Bates*
The classic episode in the history of disease pre-
vention occurred in London in 1854 (1). There was
an epidemic of cholera in the neighborhood around
Broad Street. John Snow, the hero of the story,
studied the habits of the victims and found that al-
most all obtained their waterfrom the well on Broad
Street. Swift action was taken; the pump was closed
down and the epidemic rapidly subsided. This ac-
tion was taken before there was a clear under-
standing that the disease was caused by exposure to
the bacterium Vibrio cholerae. One can imagine the
reaction that might occur today if it were proposed
to close down the pump on the basis ofevidence of
the kind obtained by John Snow. Many scientists
would point out that it had not been conclusively
demonstrated that the water was the cause of the
disease. They would be troubled because ofthe lack
of satisfactory theoretical knowledge to explain
how the water could have caused the disease. Fur-
thermore, other habits ofthose who had become ill
had not been adequately investigated, so it would
not be possible to rule out other causes of the dis-
ease. These scientists would have been correct.
Others would have pointed out that some members
ofthe community who drank from the Broad Street
well had not succumbed to cholera. Thus, even if
there were something wrong with the water, there
must be otherfactors involved, and ifthese could be
controlled, they would not have to be concerned
aboutthe water. These conclusions are also correct.
Some who consumed water from the Broad Street
well would have objected to closing it because it
was inconvenient to get their water elsewhere or
because the taste of water from other wells was not
as agreeable. Finally, if the pump had been owned
by an individual who sold the water, he would cer-
tainly have protested against closing down his busi-
ness on the basis of inconclusive evidence of
hazard.
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Although this story is about an infectious disease,
it illustrates a number of points that are also rele-
vant to the prevention of cancer or other kinds of
injury from toxic chemicals. First, ifhuman disease
and deaths are to be prevented, it is often necessary
to control exposure to chemicals for which there is
some evidence of hazard before that evidence has
reached the point that scientists would universally
regard as conclusive. The alternative, to continue
exposure until there is conclusive evidence of
human hazard, is a form ofhuman experimentation
that our society finds increasingly unacceptable.
Second, development of a disease in any indi-
vidual is the result ofcomplex interactions ofa vari-
ety of factors including his or her genetic suscepti-
bility; environmental influences on the person's
state of susceptibility that may include such things
as exposure to other substances in the environment,
the person's state of nutrition, age, and general
health; and finally the level and extent of exposure
to specific disease causing agents. These principles
hold true for cholera; not all who drank from the
Broad Street well developed cholera. These princi-
ples also apply to cancer induction; cancerdevelops
in susceptible individuals exposed to carcinogenic
agents.
Third, the incidence of disease in a population
can be reduced either by reducing exposure to
specific causative agents or through general or
specific measures that reduce the level of suscepti-
bility of the population to the causative agents. The
state of our knowledge about the specific disease
determines which measures can be applied most
successfully at any particular time in history. Dur-
ing John Snow's time, removing the supply of con-
taminated water was the most feasible approach.
Today, cholera can also be controlled through im-
munization and mortality can be reduced through
specific therapy. During John Snow's time, how-
ever, the latter options were not available. In the
control of tuberculosis, good nutrition and good
living conditions are as important as removing the
source of exposure to the bacteria through hos-
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eral health measures increase resistance of the
population to the disease agent. More specific im-
munization techniques against tuberculosis have
been developed; but their effectiveness has been a
matterofconsiderable debate formany years (3).
For cancer, the major method of prevention
available today is to prevent exposure to chemicals
and radiations capable of inducing the disease (4).
There is no doubt that genetics plays a part in sus-
ceptibility of individuals to cancer (5), but we can-
not control the genetics ofthe population. Nutrition
can undoubtedly affect the susceptibility ofan indi-
vidual to cancer. The obese have a higher incidence
of cancer than those of normal weight (6). In addi-
tion, diets from various countries appear to be as-
sociated with specific kinds of cancer (7). For
example, there is a high incidence of cancer of the
stomach in those living on the Japanese diet and a
high incidence of cancer of the colon and pancreas
in people consuming a typical American diet (8).
Whether these differences result from the presence
ofspecific carcinogenic agents in food consumed or
result from the effect ofthese diets on susceptibility
to carcinogenic agents from other sources of expo-
sure is currently unknown. Some have recom-
mended what they call a "prudent" diet, thought
likely to result in a lower susceptibility to cancer. It
may take a number of years to learn how effective
this will be.
We do know, however, that prevention of expo-
sure to carcinogenic chemicals and irradiations can
be remarkably effective in preventing the kinds of
cancer they induce. Cancer of the lung, the most
common cancer among males in the United States,
is uncommon in those who do not smoke cigarettes
(9). Stopping smoking reduces the risk for former
smokers (10). Cancer ofthe skin results from exces-
sive exposure to sunlight (11). Genetic factors in
susceptibility and resistance are well demonstrated
by this form of cancer. Dark-skinned populations
are resistant, whereas light-skinned are relatively
susceptible. The most susceptible individuals have
a rare genetic trait called xeroderma pigmentosum.
These individuals have a genetic defect that pre-
vents them from repairing damage from ultraviolet
irradiation (12). Their susceptibility is so severe that,
in the past, those with the defect have always died
from skin cancer in their adolescent or early adult
years. There is now evidence, however, that even in
the case of such extreme geneti%: susceptibility, re-
moval of exposure to the causative agent can pre-
vent the disease. Children with xeroderma pig-
mentosum who have been kept out ofsunlight have
not developed skin cancer (13). Although the ge-
netic defect that makes these peons hi-hly suscep-
tible to skin cancer cannotbe corrected, they can be
prevented from developing skin cancer by prevent-
ing exposure to the carcinogenic ultraviolet rays of
the sun.
Thus, the development of cancer is dependent
both on the level ofexposure to carcinogenic agents
and on multiple environmental and genetic factors
affecting the individual's state of susceptibility.
This concept is often lost sight of even among sci-
entists. A recent publication (14), for example, di-
vides cancers of "preventive potential" into those
"'attributable to" diet, tobacco, radiation, occupa-
tion, alcohol, and exogenous hormones. The total
adds up to 100%. Consideration of the complex
multiple interactions of environmental and host
factors involved in cancer induction suggests that
the sum of these individual contributions to cancer
induction in the American population should be sig-
nificantly greater than 100lo. Even among occupa-
tional groups that have been heavily exposed to
potent chemical carcinogens, some of the workers
have remained free of cancer (15). Other factors
must distinguish between those who develop cancer
and those who do not. The way in which these indi-
viduals metabolize the carcinogenic chemicals,
either to metabolites that directly induce cancer in
the exposed cells or to harmless ones, is undoubt-
edly one factor determining whether or not an indi-
vidual will get cancer. Metabolism appears to be
partly under genetic control (16) but is also influ-
enced by the diet (17) and by exposure to drugs or
otherenvironmental chemicals (18). Thus, it is more
reasonable to expect that the workers who develop
cancer after being exposed to an occupational car-
cinogen do so as the result oftheir exposure to the
occupational carcinogen, their genetics, their diet,
and their exposure to other environmental chemi-
cals than to simply classify these carcinogens as
occupationally induced without also tabulating the
responsibility of these other factors in their causa-
tion.
There is evidence for a synergistic action of
cigarette smoking and exposure to asbestos in the
induction oflung cancer (19). Thus, some cigarette
smokers would not have developed cancer if they
had not had an occupational exposure to asbestos
and some asbestos workers would not have de-
veloped cancer if they had not smoked cigarettes.
How can these cancers be neatly attributed to either
tobacco or occupation? Both causative factors are
important.
Most patients with xeroderma pigmentosum
would not have developed skin cancer if they had
not been so unlucky as to inherit the genetic defect.
Likewise, they do not develop skin cancer unless
they are exposed to ultraviolet light. Should we
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tients as a genetic cancer or as a cancer resulting
from exposure to ultraviolet light? Actually it is
both, and it is an oversimplification to try to classify
it as simply one orthe other.
Viewed in this light, cancer being the result of
multiple factors ofexposure and susceptibility, it is
difficult to place a true estimate on the contribution
ofexposure to occupational carcinogens to the total
incidence of cancer in the United States. Few
epidemiologic studies of occupational cancer have
been of adequate sensitivity to detect anything
smaller than a 50% increase in the incidence of
cancer over that found in the general population
(20). Weakly carcinogenic agents, that is, those
capable of inducing cancer only in the most highly
susceptible individuals at the level to which the
worker population is exposed, would not be de-
tected by most epidemiologic studies. Nevertheless
these chemicals could still result in an unacceptable
risk of cancer in exposed workers. There is some
evidence that carcinogens brought home from the
workplace on clothing may increase the incidence
ofcancer in members ofthe worker's families (21).
In addition, it is reasonable to believe that the high
incidence of cancer in counties surrounding some
chemical and other industrial plants may result from
exposure of the local population to inadequately
contained industrial carcinogens (22). Individuals in
these communities are also ofdiverse genetic stock
and exposed to other chemicals and diets that may
affect their susceptibility to cancer. Depending
upon whether these people were included in a large
study of diet as a factor influencing cancer inci-
dence or a study comparing cancer in industrialized
communities with rural communities, some ofthese
cancers might be considered to be either of dietary
or ofindustrial origin. Unfortunately, we are still in
the situation with regard to cancer induction com-
parable to that of the blind men and the elephant.
Where multiple factors of causation are involved,
those being studied will be those that are observed.
This does not indicate that other contributory
causes are not involved in the same cancers. Pre-
vention of cancer depends upon identifying what-
ever causative factors we can and controlling these
wherever we can. Occupational carcinogens are
among the causes that can be effectively controlled.
With the increasing dependence of our society on
synthetic chemicals, increasing vigilance will be re-
quired to maintainthe health ofworkers.
Ifwe are to identify chemical carcinogens before
they have caused cancer in humans or if we are to
identify chemical carcinogens that have not resulted
in a sufficiently elevated risk ofcancer induction to
be shown by epidemiologic studies, we must de-
pend on animal experiments.
It has been pointed out (23) that in an experiment
with 100 animals, ""each animal is surrogate for two
million people" in this country. Whenever a reg-
ulatory decision is made or a regulatory policy
contemplated, based on using experimental animals
as human surrogates, the question of how precisely
they reflect the true toxicologic risk to humans from
exposure to the same chemicals always arises. The
science of toxicology will have made immense
strides when it becomes able to use the results of
animal experiments to precisely predict the toxic
risk of chemical to any individual or group of hu-
mans. Unfortunately we are not there yet. The
problem is terribly complicated. Absorption, rate of
metabolism, and excretion ofenvironmental chemi-
cals may differ somewhat among species (24).
Species differ significantly in the types or relative
ratios ofmetabolites formed from any chemical (25)
and in the sensitivity of various organ systems to
the toxic effects ofthese chemicals (26). Individuals
within each of these species may show wide differ-
ences among these parameters (27) depending upon
their genetics and on modifying environmental cir-
cumstances. Susceptibility in the same individual
may fluctuate during the phases of various biologi-
cal cycles (28). Although we know these variables
exist, we do not have enough knowledge to weigh
each of them in any particular case and come up
with a reliable multiplier for converting results of
animal experiments to risk for any individual human
under his or her conditions oflife. Science left to its
own devices would respond to this situation by de-
ferringjudgment until adequate knowledge became
available. In a functioning and ongoing economy,
decisions must be made to either permit or prohibit
human exposure before this level of certainty has
been reached. Deferring judgment simply means
that the status quo is maintained. Old chemicals re-
main in use; new chemicals will not be permitted to
be used.
Much of the debate among scientists that occurs
in relation to decisions by regulatory agencies is
essentially a debate on how to weigh limited scien-
tific information to decide whether a chemical does
or does not pose a health hazard for humans. In the
absence ofscientific certainty, the same data will be
interpreted differently by different scientists. Their
interpretations are invariably colored by their own
philosophies regarding the level of assurance of
safety that should be provided before permitting
human exposure to a chemical or the amount of
evidence of hazard that should be demonstrated
before steps are taken to prevent human exposure.
Protestations that this is not the way science works
cannot obscure the fact that science is "'a very
February 1979 305human business" (29) and that scientists will be-
have like human beings in their interpretation of
evidence that is less than irrefutable. The real policy
question, then, is deciding how less than irrefutable
scientific knowledge shall be used to make a reg-
ulatory decision that may have an impact both on
human health and on the economy. This involves a
scientific determination of the most likely interpre-
tation of available scientific informatiQn and a pol-
icy decision on whether to lean toward the side of
protecting human health or the side of protecting
economic enterprise when faced with scientific un-
certainty.
There is much debate about the interpretation of
animal experiments designed to detect chemicals
that may be carcinogenic for humans. Although
epidemiologic studies ofexposed humans can make
useful contributions to our understanding ofhuman
risk, they have several drawbacks. First, informa-
tion on carcinogenicity of a chemical in humans is
only obtained after many years of exposure and
after harm has already been done to those who have
been exposed. Second, although a positive result
needs to be given very serious consideration, it is
often difficult to be sure that the correlation noted
between exposure to a chemical and an increased
cancer rate is the result ofthe chemical; since these
same individuals have probably been exposed to
many other chemicals over a period ofmany years.
Thus, additional epidemiologic investigations or
animal experiments are usually required to confirm
the original observation. Third, epidemiologic
studies are usually of fairly limited sensitivity,
especially when the exposed population is relatively
small. That is, they can only detect substantial in-
creases in cancer rates in the exposed population.
Therefore, a negative result can be used to set an
upper limit on the risk ofcancer to humans exposed
for the same time and to the same amounts of
chemical as the population under study, but cannot
eliminate the possibility that a lower level of risk
may exist. For these reasons, we are usually forced
to rely heavily on experimental studies as abasis for
judging the potential carcinogenicity of a chemical
for human beings. This practice is supported by the
observation that most known human carcinogens
are also carcinogenic in experimental animals (30),
that for the most part the same kinds of metabolic
enzymes that activate and detoxify chemical car-
cinogens are present in both human tissues and in
experimental animals (31), and that the general pro-
cess of development of similar kinds of cancer is
comparable in humans and experimental animals
(32, 33). The question is sometimes asked, "Are
there chemicals that have been shown to be car-
cinogenic in experimental animals that are not car-
cinogenic in humans?" Although it is not unreason-
able to anticipate that there might be some chemi-
cals that are carcinogenic for some other species but
not for man, we cannot answer this question defini-
tively. Most chemicals shown to be carcinogenic in
experimental animals have either been ones for
which there has been little human exposure, or have
been studied intoofew people orfortoo shortaperiod
after exposure to rule out the possibility oftheir being
able to cause cancer in man (34).
Animal experiments are usually conducted at
considerably higher levels of exposure than those
customarily occurring in humans, though in some
poorly controlled occupational settings it is possible
for workers to be exposed to high levels of car-
cinogenic chemicals (35, 36). Since this practice of
testing at high dose levels is often challenged, some
comments about it are in order. The fundamental
reason for doing so is to enhance the sensitivity of
the experimental bioassay to detect a chemical car-
cinogen. A study in 100 animals, a common size of
experimental group at the present time, can obvi-
ously not detect anything lower than the induction
of cancer in one percent of the animals. In actual
practice, statistical considerations permit only the
detection of a risk severalfold larger than this for
rare tumors and considerably larger if the types of
tumors induced are those found with significant fre-
quency in untreated control animals. This level of
risk is much higher than that which is socially ac-
ceptable in an exposed human population. In order
to detect lower levels of risk, it is either necessary
to test in much larger groups ofanimals or to test at
much higher dosage levels than those to which hu-
mans are exposed and use mathematical procedures
to estimate the level of risk from lower levels of
exposure. The former approach can be utilized by
any manufacturer who wishes to determine experi-
mentally the levels of risk from low levels of expo-
sure to his product, but in practice such an experi-
ment would often have to be so large as to be un-
feasible economically. The latter approach is
economically feasible but is based on certain scien-
tific assumptions that are debated. One ofthese as-
sumptions is that there is no threshold below which
exposure to a carcinogenic chemical entails no risk.
That is to say, although decreasing the exposure
will decrease the risk of cancer induction, there is
no level below which the risk becomes absolutely
zero until zero exposure is reached. Debate over
this question is partly a matter ofsemantics or defi-
nition ofterms. Some scientists approach this issue
as a mathematical problem by which the likelihood
of induction ofcancer becomes very, very small as
exposure becomes very, very small, but the possi-
bility still remains. Others will conclude that when
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alent ofzero. Thus, the first group might argue that
a risk of one in one billion of inducing cancer in a
finite (though perhaps tolerable) risk and not a
threshold, while the other group may argue that for
practical purposes this is so low as to be the practi-
cal equivalent of a threshold. More scientific argu-
ments for threshold may point out the possibility
that chemicals are metabolized differently at high
exposure levels than at low levels, that protective
mechanisms may be more effective at low exposure
levels than at high ones, and that repair mechanisms
may be more effective at low exposure levels than
at high levels (37). In principle, these arguments can
be used as arguments in favor ofa threshold only if
it can be shown that the carcinogenic metabolite
present at high exposure levels is totally absent at
low exposure levels (rather than simply present as a
lower proportion of total metabolites), or that de-
fense and repair mechanisms are totally effective
(rather than proportionately more effective) at low
exposure levels in contrast to high levels. In the
absence ofthis information as a general principle or
for any specific chemical under question, these ar-
guments suggest that the risk from low levels of
exposure may be less than otherwise might be pro-
jectedfromhighexposure experiments, buttheyfailto
provide convincing arguments for general concept of
threshold.
The concept of threshold is also confused be-
cause some scientists use the term to apply to indi-
viduals while others use it to apply to populations.
As discussed earlier, the sensitivity of any indi-
vidual to a chemical carcinogen will vary depending
upon his genetics, state ofhealth, age, and exposure
to a wide variety of environmental factors. Thus
more resistant individuals may be able to tolerate an
exposure level that would result in cancer for the
more susceptible. Ifthe term "threshold" is applied
to these people, the same level ofexposure may be
below the threshold for carcinogenicity of the re-
sistant individuals but above that for the sensitive
ones. When these considerations are applied on a
population basis, it can be seen that this level might
increase the total incidence of cancer in a large ex-
posed population even though the level might be
one that could be tolerated by many individuals
within it. Since approximately a quarter of the
American population will develop some form of
cancer during their lifetimes, it is apparent that
many are already over their threshold and addi-
tional exposures are likely to push more over the
limit. At the present time, we are still in a position
ofbeing unable to unequivocally decide whether or
not thresholds exist, as defined at the molecular or
population level, or to determine which individuals
in the population may or may not be able to tolerate
additional exposure from carcinogenic chemicals.
There are also debates about whether a variety of
mechanisms may exist by which chemicals increase
the incidence of cancer in a group of experimental
animals, and whether these can be sorted out into
mechanisms having differing levels of risk for hu-
mans under the conditions and levels of human ex-
posure. This is a valid scientific question, but one
difficult to answer for any individual regulated
chemical without a very extensive research effort.
Even at the general level of classes of chemicals,
the principles to be used to sort out such groupings
and to estimate the risks associated with them are
not well understood. Ifsuch an attempt were made,
one class would certainly consist ofthose chemicals
that react with DNA and are capable of causing
mutation (38), whether or not that is actually the
mechanism by which cancer is induced. Probably a
higher proportion ofscientists believe that this class
has no threshold than would agree on other classes.
Another class would be promoting agents (39). In
the experimental skin carcinogenesis model for
which this terminology was developed, it is recog-
nized that these agents have little orno carcinogenic
effect themselves, that they markedly enhance the
carcinogenicity of certain carcinogenic chemicals,
and that their effect requires repeated exposure and
is reversible in the absence of such repeated expo-
sure. Since the mechanism by which this effect oc-
curs in the skin has still notbeen adequately worked
out, it is difficult to know how widespread this pre-
cise phenomenon is for various chemicals and organ
sites. Thus, although this is a class of chemical af-
fecting the incidence ofcancer that many would re-
gard as likely to have a threshold, there are usually
practical problems involved in deciding whether or
not a chemical should be placed in this class from
the amount of data generally available to the reg-
ulator. There are also problems involved in deter-
mining the level at which a threshold may exist, and
little information is available on how a multiplicity
ofpromotors and other chemicals in the human en-
vironment may interact in an additive, synergistic,
or inhibitory way to affect the level at which a
threshold forpromoting agents may lie (40).
Another class of chemical consists of those hav-
ing hormonal effects. Most scientists in the field of
toxicology and chemical carcinogenesis believe that
these act by a mechanism different from those
chemicals that are both carcinogenic and
mutagenic. The evidence for this is not conclusive,
however. It will probably remain subject to debate
until there is a definitive understanding of the
mechanism by which carcinogenic hormones cause
cancer. Even if this mechanism is different from
February 1979 307those of mutagenic chemicals, two questions still
remain. First, are there thresholds for such effects?
Second, if a synthetic chemical is carcinogenic and
has a hormonal action, is this the only mechanism
by which it can cause cancer? On the threshold
question, the assumption is often made that since
hormones are natural chemicals ofthe human body,
there are levels that are noncarcinogenic and a small
incremental exposure over natural levels will have
no significant effect. This overlooks the fact that a
substantial proportion of human cancers occur in
organs under the control of hormones even among
individuals who have never received synthetic hor-
monal chemicals. Thus, "normal" levels of expo-
sure do appear to be related to the development of
cancer in some people. A small increase in those
levels may have a small impact on the total cancer
incidence, but is not necessarily negligible. The
problem with the second question is illustrated by
the drug, diethylstilbestrol. This drug is car-
cinogenic in experimental animals (41) and has been
shown to cause cancer ofthe vagina in the offspring
of some women who were treated with it during
pregnancy (42). It almost certainly can induce
cancer through the same mechanism as natural es-
trogens, but it also can be metabolized to products
that may be capable of binding to DNA (43) and
therefore may act through another mechanism of
carcinogenesis as well.
It is known that the caloric content ofthe diet can
influence tumor incidence, both in experimental
circumstances (44, 45) and, as indicated by obesity,
in humans (6). This effect could influence the in-
terpretation of an experiment in which caloric in-
take were not controlled among different groups of
animals. Increased caloric intake is associated with
an increased incidence of cancer, whereas a de-
creased caloric intake reduces the cancer incidence.
In the common types ofbioassay protocols in which
animals are fed ad libitum, it is ordinarily those re-
ceiving maximum exposure ofthe chemical that eat
the least. Thus, this effect would tend to underesti-
mate the risk ofcancer induction in heavily exposed
animals.
Another debated issue is the significance of be-
nign tumors as an index of carcinogenicity of a
chemical. This subject has been discussed by many
groups of scientists who have issued recom-
mendations on the interpretation ofcarcinogenicity
studies. Depending upon which report is read, one
will receive the advice eitherto base the assessment
ofcarcinogenicity only on the presence ofmalignant
tumors (46), on both malignant and benign tumors
(47), or on malignant and benign tumors when both
are present in the same organ, but not on benign
tumors when malignant tumors are not also present
(48). Thus, this is certainly an issue on which
unanimity of scientific opinion does not prevail. In
analyzing this issue it is helpful to consider the cir-
cumstances under which the distinction between
benign and malignant tumors developed and how
these apply to the problem of determining whether
or not a chemical is capable of inducing cancer.
These terms developed in the context of human
medicine where the goal was to predict the likeli-
hood that the tumor found in an individual patient
might be lethal. It was noted that tumors with cer-
tain characteristics were most likely to be lethal,
that is malignant, whereas others did not indicate a
bad prognosis. Thus, the terms benign and malig-
nant reflected the expected outcome ofthe presence
ofthe tumor in the individual patient. They bore no
relationship to the causal events leading to these
tumors and whether or not such events would pro-
duce the same or a different kind of tumor in
another individual. The guidelines fordistinguishing
between benign and malignant tumors are verygood
with some kinds of tumors, but relatively poor for
others. Thus, in the latter case, disagreement may
exist among qualifiel pathologists as to whether a
tumor is benign or malignant. The sharp distinction
between benign and malignant tumors is also
somewhat muddied by the tendency of some kinds
ofbenign tumors to progress onward to malignancy
(32).
In the experimental bioassay, we are not really
interested in whether the tumor will or will not be
lethal in the particular mouse or rat. We are in-
terested in whether these tumors indicate that the
chemical inducing them is capable ofcausing cancer
under some circumstances in exposed human be-
ings. Thus, the question is whether the tumors rep-
resent an index of carcinogenicity of the chemical
rather than whether they represent a lethal threat to
the animals in which they reside. A number of ex-
perimental studies suggest the importance of con-
sidering the presence of benign tumors as an indi-
cator that their inducing agent is capable ofcausing
malignancy. The induction of benign adenomas of
the mouse lung has been used as an indicator of
carcinogenicity. It has been shown that many
widely studied chemical carcinogens that are clearly
capable ofinducing malignancy under some circum-
stances cause an increase in this tumor type (49).
Some scientists discounted an early study showing
the induction by DDT of mouse liver tumors that
were diagnosed as benign (50) because no metas-
tases were found. These studies were stopped after
18 months. Subsequent studies lasting for a longer
period confirmed this result and also showed the
induction of some metastasizing tumors ofthe liver
(51). The induction oftumors ofthe mammary gland
Environmental Health Perspectives 308by x-ray and by carcinogenic polycyclic hydro-
carbons has been extensively studied in rats. These
carcinogenic agents are capable of inducing both
malignant adenocarcinomas and benign fibro-
adenomas ofthe mammary gland. These tumors are
similar to those found in the human breast, and, in
humans, as in the rat, the former is clearly malig-
nant and the latter benign. Studies in rats, however,
havesh6wn thatthe relative proportion ofthese two
types of tumors that are induced varies markedly
amongdifferent genetic strains ofrat(52), indicating
the importance ofgenetics in determining whethera
carcinogen will induce a benign or a malignant
tumor. Thus, it has been shown that under some
experimental conditions chemicals capable of in-
ducing malignancy will induce mostly benign
tumors. It is not clear that there are any chemicals
capable only of inducing benign tumors and never
inducing malignancies, though the possibility can-
not be ruled out that there may be some. As with
many other questions, the regulator must make a
decision before arguments have ceased within the
scientific community. These may either lean toward
protecting human health or toward protecting
economic enterprise. In the former case a signifi-
cant increase in benign tumors would be considered
to be an index of carcinogenicity unless solid evi-
dence were provided that the particular chemical
was only capable ofinducing benign tumors. In the
latter case less weight might be placed on benign
tumors.
In a recent publication, Tomatis (53) described
the delays that occurred in controlling exposure to a
number of human carcinogens. Delays resulted
from failure to act on experimental data in the ab-
sence of human evidence, failure to act on human
evidence in the absence of experimental data, and
even failure to act on both human and experimental
evidence when tumors induced in animals were ofa
different type from those found in exposed human
populations. Meanwhile, additional humans suf-
fered from continuing induction of cancer. It will
always be possible to find arguments for the uncer-
tainty ofany set ofdata on carcinogenicity. Preven-
tion of cancer requires that action be taken on the
basis of reasonable evidence of the possibility of
hazard even if this may result sometimes in what
may be proven later to be unnecessary controls. As
further understanding of carcinogenicity develops,
it should be possible to reach agreater consensus on
risk levels. Action to protect public health cannot
be delayed until then.
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